Schedule 13G
GPCR Schedule 13G filing by Capital Research Global Investors
Capital Research Global Investors reported beneficial ownership of 10.6M shares, representing 6.2% of Structure Therapeutics Inc. in this filing.
FiledNov 12, 2024
Ownership dateSep 30, 2024
Reported shares10.6M
Reported ownership6.2%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
10.6M
Shared voting power
10.6M
Sole dispositive power
10.6M
Shared dispositive power
10.6M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$36.97as of Nov 12, 2024
Latest tracked price$50.53as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Capital Research Global Investors
- CIK
- CIK0001422848
- Accession
- 0001422848-24-000335
- Form
- Schedule 13G
Read the filing in context